|
Camp4 Therapeutics Corporation (NASDAQ: CAMP) |
|
Camp4 Therapeutics Corporation
CAMP's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Camp4 Therapeutics's sales fell
by -99.08 % in the fourth quarter of 2024 from the same quarter a year ago.
Ranking at No. 1904
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.85 %
Camp4 Therapeutics net loss increased from $-4 millions, to $-38 millions in fourth quarter of 2024,
• More on CAMP's Growth
|
|
Camp4 Therapeutics realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.29 in trailing twelve-month period. |
Company |
-0 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.08.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.02.
• More on CAMP's Valuation
|
|
|
|
|
Camp4 Therapeutics realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.29 in trailing twelve-month period. |
Company |
-0 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.08.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.02.
Camp4 Therapeutics Price to Book Ratio is at 0.15 lower than Industry Avg. of 75.38. and higher than S&P 500 Avg. of 0.01
• More on CAMP's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com